DTIC Public Document 69c5ad4b9452b6f56b39dbb7e69008f2

Document Details

Document Type
Cost Item
Publication Date
Oct 01, 2020
Source ID
69c5ad4b9452b6f56b39dbb7e69008f2
Current Year Amount Norm
0
Group Name
Product Development
Name
CMDR-B - Bacterial Therapeutics Core Program Evaluation of BAXDELA in the Treatment of Inhalational Disease
Performing Activity
US Army Medical Research Institute of Infectious Disease (USAMRIID)
Prior Year Amount Norm
1375000

Related Documents